Is Integ. Proteins overvalued or undervalued?

As of 19 September 2025, the valuation grade for Integ. Proteins has moved from risky to fair, indicating a more stable outlook for the company. The stock is currently fairly valued, with a PE ratio of 13.34, an EV to EBITDA ratio of 13.31, and a PEG ratio of 0.10, suggesting that the stock may be undervalued relative to its growth potential.
In comparison to peers, Integ. Proteins' valuation metrics are significantly more attractive than those of Manorama Industries, which has a PE ratio of 57.18 and an EV to EBITDA of 36.63, categorizing it as very expensive. In contrast, CIAN Agro is also fairly valued with a PE of 45.93. Despite recent stock performance showing a year-to-date decline of 51.72% against a Sensex return of 5.74%, the long-term outlook appears promising, supported by a strong historical return of 192.74% over three years.